CIK: 0001907884 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value ($000): $474,567 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTRA | NATERA INC | 2,018,360 | $88,445 | 18.6% | $52.15 | -8.7% | COM | 632307104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,272,915 | $54,618 | 11.5% | $17.42 | +28.8% | COM | 87164F105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1,600,127 | $44,980 | 9.5% | $32.54 | -5.8% | COM NEW | 15117B202 |
| VERA | VERA THERAPEUTICS INC | 1,536,181 | $32,736 | 6.9% | $18.89 | -0.9% | CL A | 92337R101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 151,009 | $31,618 | 6.7% | $223.56 | 0.0% | COM | 91307C102 |
| SNY | SANOFI | 600,000 | $22,812 | 4.8% | $38.02 | — | SPONSORED ADR | 80105N105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,000,000 | $20,510 | 4.3% | $18.54 | -3.0% | COM | 92790C104 |
| BIIB | BIOGEN INC | 75,000 | $20,025 | 4.2% | $229.95 | -7.6% | COM | 09062X103 |
| PCVX | VAXCYTE INC | 698,638 | $16,767 | 3.5% | $22.52 | +12.6% | COM | 92243G108 |
| — | BURNING ROCK BIOTECH LTD | 6,703,863 | $16,022 | 3.4% | $3.47 | — | SPONSORED ADS | 12233L107 |
| GSK | GSK PLC | 500,000 | $14,715 | 3.1% | $29.43 | — | SPONSORED ADR | 37733W204 |
| COGT | COGENT BIOSCIENCES INC | 985,155 | $14,699 | 3.1% | $6.83 | +100.8% | COM | 19240Q201 |
| — | CONCERT PHARMACEUTICALS INC | 1,673,041 | $11,209 | 2.4% | $5.21 | — | COM | 206022105 |
| TVTX | TRAVERE THERAPEUTICS INC | 416,729 | $10,268 | 2.2% | $26.37 | -2.0% | COM | 89422G107 |
| LQDA | LIQUIDIA CORPORATION | 1,692,402 | $9,207 | 1.9% | $4.41 | +27.3% | COM NEW | 53635D202 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 131,220 | $8,936 | 1.9% | $31.16 | — | COM | 37890U108 |
| — | AMARIN CORP PLC | 6,720,148 | $7,325 | 1.5% | $1.97 | — | SPONS ADR NEW | 023111206 |
| FOLD | AMICUS THERAPEUTICS INC | 676,849 | $7,066 | 1.5% | $10.09 | +10.4% | COM | 03152W109 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 435,117 | $5,482 | 1.2% | $10.32 | +24.8% | COM | 09058V103 |
| WVE | WAVE LIFE SCIENCES LTD | 1,397,479 | $5,045 | 1.1% | $3.78 | -12.4% | SHS | Y95308105 |
| — | SERES THERAPEUTICS INC | 772,820 | $4,962 | 1.0% | $7.06 | — | COM | 81750R102 |
| — | AKOUOS INC | 718,394 | $4,856 | 1.0% | $6.20 | — | COM | 00973J101 |
| GOSS | GOSSAMER BIO INC | 386,349 | $4,628 | 1.0% | $10.19 | +21.8% | COM | 38341P102 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 519,212 | $4,377 | 0.9% | $9.46 | 0.0% | COM | 74366E102 |
| OLMA | OLEMA PHARMACEUTICALS INC | 1,399,633 | $3,863 | 0.8% | $7.18 | -40.9% | COM | 68062P106 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 731,521 | $2,941 | 0.6% | $9.21 | — | SPONSORED ADS | 152309100 |
| — | AFFIMED N V | 676,675 | $1,394 | 0.3% | $4.13 | — | COM | N01045108 |
| PBYI | PUMA BIOTECHNOLOGY INC | 559,769 | $1,327 | 0.3% | $4.34 | -32.7% | COM | 74587V107 |
| XENE | XENON PHARMACEUTICALS INC | 28,792 | $1,039 | 0.2% | $29.88 | +20.3% | COM | 98420N105 |
| — | CONNECT BIOPHARMA HLDGS LTD | 739,649 | $954 | 0.2% | $1.53 | — | ADS | 207523101 |
| RLMD | RELMADA THERAPEUTICS INC | 300,000 | $803 | 0.2% | — | — | Put | 75955J402 |
| CABA | CABALETTA BIO INC | 527,805 | $343 | 0.1% | $10.67 | -88.7% | COM | 12674W109 |
| — | TRICIDA INC | 260,000 | $338 | 0.1% | — | — | Call | 89610F101 |
| — | TRICIDA INC | 97,600 | $122 | 0.0% | — | — | Put | 89610F101 |
| — | NEOLEUKIN THERAPEUTICS INC | 120,368 | $77 | 0.0% | $4.82 | — | COM | 64049K104 |
| — | CATALYST BIOSCIENCES INC | 90,188 | $45 | 0.0% | $0.91 | — | COM NEW | 14888D208 |
| LQDA | LIQUIDIA CORPORATION | 507,700 | $13 | 0.0% | $4.41 | +27.3% | Call | 53635D202 |